AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06446141 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Osteopathic technique
Description: Patients will be positioned in a supine position. Osteopathic technique will consist of supoccibital release, soft tissue release of thoracic outlet, mobilization of cervical facet joints, stretching of scalene anterior, scalene medius, upper trapezius, and levator scapula, pectorals major and minor. Subsequently, cost vertebral and cost transverse joint mobilizations will be applied using rib elevation. Then, manipulation of the vertebrae the levels between C6 and T1 will be applied using thrust mobilization technique. Afterwards, mobilization of the first rib will be applied. Finally, mobilization of the upper cervical spine will be performed.
Study NCT05681312 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: systemic proteolytic enzyme (Tibrolin)
Description: Tibrolin is a fixed dose combination of(Trypsin 48 mg, Bromelain 90 mg) and a bioflavonoid (Rutoside 100 mg)
Study NCT05681312 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Amoxicillin 500mg+metronidazole 500mg+ doliprane 100mg
Description: Amoxicillin is given with metronidazole 500mg 1\*3' Doliprane 1000mg is given 1\*1
Study NCT05015166 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Internet delivered self-help program without therapist support
Description: During 8 weeks of treatment participants are taught how emotional conflicts may underlie and perpetuate symptoms of social anxiety. They are also taught how to observe their own anxiety and emotional avoidance (i.e. defenses) and how to gradually approach previously warded off feelings. The final part of the program contains material on how one may express previously warded off emotions to improve important relationships. The treatment program consists of text, videos and a series of experiential exercises.
Study NCT06168500 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Test group
Description: 3.0mm diameter implant
Study NCT05278572 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Management and Relaxation Training/Expressive Supportive Therapy (SMART/EST)
Description: Cognitive-behavioral stress management/expressive supportive therapy (CBSM+) group targeting depression
Study NCT06168500 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Control group
Description: 4.0 diameter implant + guided bone regeneration
Study NCT05520294 — intervention group
Intervention type: OTHER
Intervention: High-performance liquid chromatography-tandem mass spectrometry assays
Description: Paraffin blocks will be requested for slide creation, and at least 12 mL of whole blood will be collected in 2 green top tubes, centrifuged, and plasma transferred for storage at -80 C until further processing
Study NCT05217849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai Chi
Description: Tai Chi is an ancient Chinese form of exercise/martial art that involves a series of movements performed in a slow, focused manner and accompanied by deep breathing.
Study NCT05217849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preventing Loss of Independence through Exercise (PLIE)
Description: PLIE is a gentle, mindful movement exercise program that integrates elements of Eastern and Western exercise modalities to develop mindful body awareness and enhance social connection.
Study NCT05217849 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health and Wellness Education
Description: This on-line class will consist of hour-long lectures/talks about various topics related to healthy aging and wellness.
Study NCT06317935 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ArmeoSenso
Description: ArmeoSenso is an upper extremity virtual reality application with three motion sensors and one hand grip sensor. The device detects the person's body, arm, forearm and hand movements and displays the reflection of the movements on the screen. The application includes studies on upper extremity functions.
Study NCT06317935 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Traditional Rehabilitation
Description: It includes traditional occupational therapy and physiotherapy approaches.
Study NCT04738708 — intervention group
Intervention type: OTHER
Intervention: Patients referred to CGS at NCCS for HBOC or Lynch syndrome pre-test genetic counselling.
Description: Patients are given a series of questions evaluating cognitive and psychosocial outcomes, either via hardcopy in-person or online internet-facing questionnaire.
Study NCT05624775 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Culinary Medicine
Description: The virtual curriculum will include five 90-minute sessions (to be held weekly or bi-weekly). Participants will cook and engage virtually (with video and sound on) from their home kitchens via the digital platform. Participants will also be expected to shop for groceries ahead of the sessions to participate in the program. A gift card will be provided for groceries ($20 per class = $100 total).Asynchronous virtual educational content (cooking skills videos, animated nutrition education videos, and additional recipes) will be provided to engage and retain participants beyond initial sessions. Recipes will provide enough food for a family of four. clinic patients
Study NCT06583850 — intervention group
Intervention type: OTHER
Intervention: The Neck Disability Index
Description: The Neck Disability Index (NDI) is the most widely used self-report tool to assess neck pain status, and provides information not only about pain experiences but also about a person\&#39;s functional status. The NDI consists of 10 questions related to pain, functional activities, self-care, and quality of life that are measured on a 6-point scale (0, no disability; 5, full disability). The numeric score for each item is summed for a score ranging from 0 to 50; 0-4 points are defined as no disability, 5-14 points as mild disability, 15-24 points as moderate disability, 25-34 points as severe disability and above 35 points as complete disability.
Study NCT06583850 — intervention group
Intervention type: OTHER
Intervention: Visual analog scale (VAS)
Description: A 10 cm VAS numbered from 0 to 10 was used for the assessment. 0 indicates no pain and 10 indicates unbearable pain. Participants were asked to mark a point between 0-10 according to their pain status
Study NCT06583850 — intervention group
Intervention type: OTHER
Intervention: Pittsburgh Sleep Quality Index
Description: Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a 19-item self-report questionnaire
Study NCT06583850 — intervention group
Intervention type: OTHER
Intervention: Cervical Range of Motion Assessment
Description: Active Cervical Range Of Motion was measured with a universal goniometer in all three planes of motion in the cervical region: lateral flexion (frontal plane), axial rotation to both right and left sides (horizontal plane), and flexion-extension (sagittal plane).
Study NCT05678855 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A randomızed Controlled Study with pre-test and post-test
Description: The intervention in this study is to apply multimedia-based instruction in distance education to the experimental group. control group students received distance education through traditional teaching. Experimental group students received distance education through interactive teaching prepared with multimedia tools. Experimental group, interactions were made using applications such as Icebreaker, Puzzle, QR code, Mentimeter, and Padlet. In addition, animation, infographics, animated slides (Multimedia tools) were used for the experimental group.In the control group, plain narration was given. Tests were administered to both groups before and after the intervention.
Study NCT06254066 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab plus Fluzoparib
Description: Adebrelimab combined with Fluzoparib in HRD-positive HR +/HER2- advanced breast cancer
Study NCT05415020 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle Behavior Protocol
Description: Virtual training on building a skillset to improve lifestyle behavior that reduces migraine attacks
Study NCT05415020 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Behavior Protocol
Description: Virtual training on the disease of migraine and how migraine can progress to chronic migraine.
Study NCT06490692 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction Training
Description: The affected limb will have a cuff placed proximally and inflated to occlude the blood flow by 40% attested using a golden standard vascular doppler after which the individuals will perform the strengthening program set forth by the physical therapist. This is preceded by other tennis elbow interventions such as ultrasound, stretching, and deep friction massage at the extensor origin.
Study NCT06490692 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Strength Training
Description: The individuals in this group will undergo the same conventional physical therapy program as the other group including ultrasound, stretching, and deep friction massage. In addition, they will undergo the same strengthening program set forth by the physical therapist however with no blood flow restriction of any kind.
Study NCT05388578 — intervention group
Intervention type: DEVICE
Intervention: Blood pressure monitor
Description: Participants will receive the Withings BPM connect monitor and do weekly self-measurements of blood pressure.
Study NCT05388578 — intervention group
Intervention type: DEVICE
Intervention: Weighting scale
Description: Participants will receive the Withings Body scale and do weekly self-measurements of their body weight and BMI.
Study NCT05388578 — intervention group
Intervention type: DEVICE
Intervention: Activity tracker
Description: Participants will receive the Withings Move to automatically keep track of their number of steps and activity type.
Study NCT05388578 — intervention group
Intervention type: DEVICE
Intervention: ECG device
Description: Participants will receive the Withings Move ECG to make daily measurements of heart rhythm, an algorithm will detect abnormalities in heart rhythm such as atrial fibrillation.
Study NCT04683237 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liraglutide Injection
Description: Initiate liraglutide with a dose of 0.6 mg daily for one week. After one week at 0.6 mg per day, increase the dose to 1.2 mg daily in a week, and increase the dose to 1.8 mg daily after at least one week of treatment with the 1.2 mg daily dose. If the patients can not tolerate 1.8mg per day, decrease the dose to the max tolerable dose.
Study NCT06518876 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KQ-2003 CAR T-cells
Description: KQ-2003 CAR T-cell therapy involves autologous chimeric antigen receptor T-cells, capable of targeting both human B cell maturation antigen (anti-BCMA CAR) and CD19 antigen molecules (anti-CD19 CAR) simultaneously as a cellular therapy.
Study NCT04683237 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Megestrol Acetate 160 MG
Description: 160mg po qd
Study NCT04683237 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Megestrol Acetate 160 MG
Description: 160mg po qd
Study NCT05672914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tablet-based sustained care
Description: A tablet-based motivational-interviewing intervention, tailored specifically to smokers with psychiatric disorders, to motivate the use of evidence-based tobacco treatment and cessation in cigarette smokers upon discharge from an inpatient psychiatric hospitalization. In addition, participants will receive standard hospital tobacco care (see Usual Care Arm).
Study NCT06089083 — intervention group
Intervention type: OTHER
Intervention: Physical function assessment
Description: Physical assessments of frailty will be conducted in person.
Study NCT06089083 — intervention group
Intervention type: OTHER
Intervention: Self-reported Assessments and Questionnaires
Description: Quality of life questionnaires and self-reported measures will be provided to complete during the course of the study
Study NCT06089083 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery (Standard of Care, Non-Interventional)
Description: Surgical data will be reviewed via medical record
Study NCT05307159 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: bean protein supplement
Description: They will have a snack with bean protein for 21 days Participants will follow their usual diet, which will be quantified and evaluated.
Study NCT05715814 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 MG
Description: PO once daily
Study NCT05156424 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: An individualised, progressive and autoregulated exercise programme, supervised by a trained professional.
Study NCT05728008 — intervention group
Intervention type: DRUG
Intervention: Ustekinumab
Description: a human monoclonal antibody to interleukin IL 12/23 p40. It is indicated in the treatment of adult patients with moderately to severely active UC. The induction phase consists of approximately 6 mg/kg intravenous dose administration. After the induction, the maintenance phase consists of a 90mg subcutaneous dose every 8 weeks.
Study NCT05728008 — intervention group
Intervention type: DRUG
Intervention: Tofacitinib
Description: Jak inhibitor. It is indicated in the treatment of adult patients with moderately to severely active UC who have experienced inadequate response or have lost the response or who are intolerant to conventional therapy or to a biological agent. The induction phase consists of 10mg twice daily for 8 to 16 weeks. After the induction, the maintenance phase consists of 5mg x twice daily.
Study NCT04045236 — intervention group
Intervention type: OTHER
Intervention: Registry
Description: Data collection
Study NCT06155916 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: Pregabalin administration and titration to the highest dosage that the patient tolerates. The patient continues with the highest dose for one month and the pre-intervention studies are repeated.
Study NCT05312931 — intervention group
Intervention type: OTHER
Intervention: OSCE
Description: Students undergo OSCE (objective structured clinical exams). It means students will perform CPR for 2 min and their success rate will be monitored.
Study NCT05978037 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: RH5.1 and/or RH5.2-VLP with Matrix-M
Description: The RH5.1 protein consists of the entire full-length ectodomain of the PfRH5 antigen (amino acids E26 - Q526) with the sequence based on the 3D7 clone of P. falciparum.~The RH5.2 protein consists of the stabilised core region of PfRH5 antigen with SpyTag fused at the C-terminus. The RH5.2-SpyTag protein is conjugated to hepatitis B surface antigen (HBsAg)-SpyCatcher to produce the final RH5.2-VLP vaccine.~The Matrix-M has been developed and manufactured by Novavax AB and is presented as a liquid solution in a glass vial.
Study NCT05865977 — intervention group
Intervention type: DEVICE
Intervention: diaphragmatic tissue Doppler imaging，dTDI
Description: dTDI was performed at the end of the SBT to assess excursion, velocity, and acceleration.
Study NCT04432675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hydroxyethl starch
Description: 10 ml/kg hydroxyethl starch as well as goal-directed fluid therapy with 3ml/kg hydroxyethl starch
Study NCT04432675 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lactated Ringer's solution
Description: 10 ml/kg Lactated Ringer's solution as well as goal-directed fluid therapy with 3ml/kg Lactated Ringer's solution
Study NCT04718129 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth Mindful Awareness Program (YMAP)
Description: The Mindfulness Intervention is an internet-based program that involves a coach. It is 9 weekly sessions and involves practicing the skills between sessions.
Study NCT06227637 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Local Muscle Vibration compared to Muscle energy technique in SIJD
Description: Apply Local Muscle Vibration compared to Muscle energy technique on patients with sacroiliac joint dysfunction and note the effect on pain intensity, pain pressure threshold, functional disability, and innominate angle tilt in SIJD.
Study NCT06450730 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy: face-to-face + app
Description: This group will receive three 1-hour face-to-face CBT sessions (1,3,8). Participants will be involved in psychoeducation and practical activities related to psychological variables crucial for the adequate management of the disease (emotion regulation, self-efficacy, psychological flexibility, decision-making, etc.). These activities will include role-playing, discussions, and assignments to highlight the importance of emotions, thoughts, and healthy behaviors in managing diabetes and and their impact on the quality of life.~For the online sessions, an app will be developed to complement the face-to-face intervention. Participants will engage in 5-weeks of exercises with weekly activities related to the intervention content (2,5,6,7). The structure of the activities will mirror that of the face-to-face sessions and will include tasks, self-report instruments, reinforcement and activity monitoring. In addition, the app will incoportate multiple resources (texts, slides, videos).
Study NCT05752006 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Repeated trunk flexion
Description: A 60-min intermittent trunk flexion protocol. Participants will sit on a standard height sit, with their knees bent at approximately 90° with their hands crossed on their chest. They will perform 40 sets of 60 s of maintaining a flexed position, interspersed with 30 s of rest. Participants will achieve the flexed position by tilting the pelvis posteriorly and leaning forward. During rest, participants will sit up straight without leaning on the support.
Study NCT05752006 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repeated trunk flexion
Description: A 60-min intermittent trunk flexion protocol. Participants will sit on a standard height sit, with their knees bent at approximately 90° with their hands crossed on their chest. They will perform 40 sets of 60 s of maintaining a flexed position, interspersed with 30 s of rest. Participants will achieve the flexed position by tilting the pelvis posteriorly and leaning forward. During rest, participants will sit up straight without leaning on the support.
Study NCT05064930 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic Bifidobacterium lactis
Description: The probiotic will be administered orally over a period of 12 weeks.
Study NCT05064930 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic Bacillus coagulans
Description: The probiotic will be administered orally over a period of 12 weeks.
Study NCT05064930 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin as a placebo will be administered orally over a period of 12 weeks. The taste and appearance of the placebo will be similar to those of the probiotic formulation.
Study NCT05173324 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HPV vaccine
Description: Licensed HPV vaccines (bivalent, quadrivalent, or nonvalent) available in the country of the study site
Study NCT05799118 — intervention group
Intervention type: GENETIC
Intervention: GWAS
Description: The study will perform a GWAS experiments for all recruited subjects. The blood sample will be collected during routine clinical visits, only if DNA is not already available in existing biobanks. All individuals will provide consent for participation in the study.
Study NCT05250830 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TrueRelief device
Description: TrueRelief is an FDA-cleared treatment for chronic intractable pain, and as an adjunctive procedure in the management of post-surgical and post-traumatic acute pain. This 20,000 Hz high frequency electrical procedure is provided by clinicians trained in the use of the device and delivered via handheld steel-tipped probes to the source of pain and where pain is experienced.
Study NCT05250830 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham TrueRelief device
Description: The placebo device looks and operates identically to the experimental TrueRelief device but will not emit any high frequency current.
Study NCT06482580 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF exercise
Description: Ankle and foot exercises practiced for 6 weeks.
Study NCT06482580 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clam exercise
Description: Hip exercise practiced for 6 weeks.
Study NCT06482580 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short-foot exercise
Description: Foot exercise practiced together for 6 weeks.
Study NCT06482580 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Short-foot exercise
Description: Foot exercise practiced together for 6 weeks.
Study NCT06243822 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: ketamine is initiated at 0.5 mg/kg/h and titrated by 0.25 mg/kg/h every 15 minutes to a maximum dosage of 4 mg/kg/h to achieve appropriate sedation.
Study NCT06243822 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Propofol is initiated at 0.3 to 0.6 mg /kg/hr. and titrated by 0.3 to 0.6 mg/kg/h every 5 to 10 minutes up to a maximum dosage of 4.5 to 4.8 mg/kg/hr. to achieve appropriate sedation.
Study NCT06070740 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
Description: Combination therapy includes:~Durvalumab: intravenous infusion with a fixed dose of 1500 mg on day 1, repeated every 3 weeks ± 3 days; Chemotherapy: Oxaliplatin 130mg/m2 intravenous infusion on day 1, capecitabine 1000mg/m2, orally, twice a day, from day 1 to day 14; repeated every 3 weeks ± 3 days;~After 6 cycles of combination therapy, maintain with durvalumab 1500 mg every 4 weeks ± 3 days for 2 years. Terminate the trial if confirmed disease progression, initiation of other anti-tumor therapy, unacceptable toxicity, withdrawal of informed consent or other reasons considered by the investigators.